Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Robinson

Showing results (341-350 of 348) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 348 results.
Vaccine|January 26, 2007
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicityBarry S Peters, Walter Jaoko, Eftyhia Vardas, et al.
British Journal of Haematology|February 23, 2021
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patientsRory McCulloch, David Lewis, Nicola Crosbie, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2024
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer: KEYNOTE-782Jair Bar, Emilio Esteban, Delvys Rodríguez-Abreu, et al.
Cancers|July 2, 2021
A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted AnalysisMichael Yan, Samantha Sigurdson, Noah Greifer, et al.
Scientific Reports|February 18, 2021
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulationAlexander Roberts, Lindsay Bentley, Tina Tang, et al.
BMJ Open Gastroenterology|February 1, 2024
CD, or not CD, that is the question: a digital interobserver agreement study in coeliac diseaseJames Denholm, Benjamin A Schreiber, Florian Jaeckle, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2020
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226Rosalyn A Juergens, Desiree Hao, Peter M Ellis, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
Pageof 35

Showing results (341-350 of 348) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 348 results.
Vaccine|January 26, 2007
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicityBarry S Peters, Walter Jaoko, Eftyhia Vardas, et al.
British Journal of Haematology|February 23, 2021
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patientsRory McCulloch, David Lewis, Nicola Crosbie, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2024
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer: KEYNOTE-782Jair Bar, Emilio Esteban, Delvys Rodríguez-Abreu, et al.
Cancers|July 2, 2021
A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted AnalysisMichael Yan, Samantha Sigurdson, Noah Greifer, et al.
Scientific Reports|February 18, 2021
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulationAlexander Roberts, Lindsay Bentley, Tina Tang, et al.
BMJ Open Gastroenterology|February 1, 2024
CD, or not CD, that is the question: a digital interobserver agreement study in coeliac diseaseJames Denholm, Benjamin A Schreiber, Florian Jaeckle, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2020
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226Rosalyn A Juergens, Desiree Hao, Peter M Ellis, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
Pageof 35